Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Welcome to Arjo’s Capital Markets Day on March 12, 2019

Arjo invites analysts, institutional investors and the media to the company’s first Capital Markets Day to be held at Arjo’s head office at Hans Michelsensgatan 10, in Malmö, Sweden on March 12, 2019. The presentations will begin at 11:00 a.m. and end at about 4:30 p.m. Registration will open at 10:30 a.m. The purpose of the Capital Markets Day is to provide an update of Arjo’s operations and greater understanding of some of Arjo’s most important areas, such as the US market, trends in long-term care and future solutions for better care. “The Capital Markets Day gives us an

Parans receives multimillion order for tunnel project in Holland

Today, Parans has received the signed agreement from the international consortium COMOL5, which runs the infrastructure project that Parans has earlier informed about. The order value for Parans amounts to approximately SEK 17.8 million. The Parans system will be installed in both tunnel entrances and will lead the sunlight into the tunnel in a way that previously has been impossible. Photo: Parans and COMOL5 Parans and COMOL5 have today signed an agreement whereby Parans will deliver sunlight via the Parans system in this innovative infrastructure

Kati Kivimäki is the new Managing Director of Mall of Tripla, Helsinki

YIT Corporation Press release 14 February, 2019 at noonKati Kivimäki, MBA (45), has been appointed as the Managing Director of Mall of Tripla, the shopping centre that will be opened in Central Pasila in autumn 2019. She will start in the position in the spring. Kivimäki is a trade and marketing professional whose career has led her to accumulate diverse experience in the shopping centre business, retail, fashion and e-commerce. She will come to Tripla from Shopping Centre Mylly, which she has been managing since 2016.  “Transferring to a management position in the shopping centre

Decor paper capacities in China for the Felix Schoeller Group

With effect from January 1st, 2019, the Chinese joint venture of the Felix Schoeller Group, Winbon Schoeller New Materials, is the majority shareholder of the Chinese decor paper producer Grandrich. Grandrich is now trading under the name Winbon Technocell New Materials Co., Ltd. With this acquisition, the Felix Schoeller Group is securing production in the world's largest growth market for decor papers, thus further expanding its international presence and strategic position. The acquisition of a majority stake in Winbon Technocell through the Chinese joint venture is another important

Correction: Friday mine in Idaho starts initial ore production in December

In the year-end report that was publicly announced on the 14th of February 2019 at 07:45 a.m. CET the information in the second part of section SIGNIFICANT SUBSEQUENT EVENTS was incorrect. The correct and updated version is: Endomines commences on 14 February 2019 the sale of an up to EUR 5 million senior secured bonds and warrants. The bond carries a coupon of 12.0 per cent and has 3-year maturity. The number of the associated warrants is 5,555,555 and their exercise price is EUR 0.90 per warrant.Endomines AB, Stock Exchange Release 14 February 2019 at 07:45 CET Friday mine in Idaho

Recipharm announces all its facilities are ready for EU serialisation

Recipharm, the contract development and manufacturing organisation (CDMO), today announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadline. During the period 2016-2018, the CDMO invested EUR 35 million into its operations and launched a three-year programme to provide a compliant serialisation solution for its customers, ahead of the introduction of the EU Falsified Medicines Directive (EU FMD) and the US Drug Supply Chain Security Act (

Record-high result for Södra

Net sales for full-year 2018 rose 18 percent to SEK 24,230 million with operating profit of SEK 4,508 million, the best in Södra’s history. The Board proposes a dividend of SEK 1,795 million. Return on capital employed was 24 percent. All business areas delivered a positive result.Consolidated net sales for full-year 2018 rose 18 percent to SEK 24,230 million (20,518), attributable to a favourable global economy, high demand and higher prices for paper pulp and sawn timber products. Operating profit for the year totalled SEK 4,508 million (1,917). The operating margin was 19 percent (9).

Capio continues building its digi-physical healthcare offering in Sweden

Capio has signed an agreement to acquire the primary care center Tibra Medica with operations in Kista in the western part of Stockholm, Sweden. The unit adds 7,000 listed patients to Capio’s network of about 900,000 listed patients in Sweden. The acquisition strengthens Capio’s digi-physical network of digital healthcare services and physical consultations in the Stockholm area.The Tibra Medica primary care center is located in Kista, which is a fast-growing part of the Stockholm area. Tibra Medica fits well with Capio’s existing primary care centers in Stockholm and adds to Capio’s

Fellow Finance`s financial statements release 2018

Fellow Finance in strong growth: Turnover grew 38,2% and profit 34,7% Financial Year 2018 in brief              · Turnover was 12,0 million euros (8,7), growth 38,2% · EBIT was 3,4 million euros (2,5), growth 34,7% · Adjusted EBIT was 3,5 million euros (2,5), growth 41,7% · EBIT margin was 28,1% · Adjusted EBIT margin was 29,5% · Profit was 0,8 million euros · Adjusted profit was 1,7 million euros · Earnings per share (EPS) was 0,13 euros (0,19) · Adjusted earnings per share (Adjusted EPS) was 0,28 (0,19) · The Company was listed on Nasdaq First North

UPM Raflatac launches new hotmelt adhesive for demanding wine, spirits, and craft beverage applications

(UPM Raflatac, Helsinki, 14 February 2019 at 11:00 EET) - UPM Raflatac is expanding its portfolio of solutions for wine, spirits, and craft beverage labeling with the introduction of RH30, a new high-performance hotmelt adhesive that brings significant benefits for label converters and brand owners alike. RH30 combines excellent high-speed converting and dispensing properties with the reliable adhesion and moisture resistance needed to keep labels firmly in place and looking good for the lifetime of the product - even in ice-bucket conditions. "The wine, spirits, and craft

Year End Report  01/01/2018 – 31/12/2018

Summary of Q1-Q4 2018 The following summary refers to the period 1/1/2018 – 31/12/2018,compared to 1/1/2017 – 31/12/2017 · Net sales for this period totaled to SEK 1,237,988 (SEK 191,345) · Operating result for the period of SEK -6,840,659 (SEK -8,958,852) · Cash and bank balance SEK 6,819,997 (SEK 15,660,371) · Capitalized development costs of SEK 1,370,801 (SEK 1,428,220) · Average number of registered shares 9,877,264 (8,788,203 shares) · Result per share* SEK –0.69 (SEK -1.02) · Equity Ratio 82.7% (93.8%) *Result per share is calculated on the average number

Fortum-Rusnano wind investment fund starts cooperation in the Saratov Region in Russia

FORTUM CORPORATION ONLINE NEWS 14 February 2019  The Government of Saratov Region in Russia and the Fortum-Rusnano wind investment fund have signed a non-binding cooperation agreement to build wind power plants with the total installed capacity of up to 300 MW in the Saratov region in 2019-2023. The agreement was signed on the sidelines of the Russian Investment Forum in Sochi. The document was signed by Governor of Saratov Region Valeriy Radaev and Alexander Chuvaev, Executive Vice President of Fortum's Russia Division. The agreement defines the general principles for cooperation of

Li-Huei Tsai receives The Hans Wigzell Research Foundation's science prize amounting to USD 100,000

The Hans Wigzell Research Foundation (Hans Wigzells forskningsstiftelse) will today award its third annual scientific prize to the neuroscientist Professor Li-Huei Tsai at Massachusetts Institute of Technology (MIT) in Cambridge, USA. Professor Tsai is to receive the prize of USD 100,000 for her pioneering research on the causes and possible therapy of Alzheimer's disease.The research, carried out at Picower Institute for Learning and Memory Department of Brain and Cognitive Sciences Massachusetts Institute of Technology has rapidly resulted in ongoing, advanced clinical trials on Alzheimer'

Correction: Stora Enso’s Annual Report 2018 published

STORA ENSO OYJ ANNUAL FINANCIAL REPORT 14 February 2019 at 10.10 EETCorrection: Links to the reports were wrong Stora Enso’s Annual Report 2018 has been published at storaenso.com/annualreport2018 . The Annual Report 2018 consists of four sections: Strategy, Sustainability, Financials and Governance. Strategy explains how our transformation is progressing and how we create value as a renewable materials company, highlighting key events from all divisions. Sustainability covers Stora Enso’s social, environmental, and economic sustainability

FSSC 22000 food safety certificates for Metsä Board’s Kyro, Äänekoski and Husum mills

Metsä Board Corporation press release 14.2.2019Metsä Board, a leading European producer of premium paperboards and part of Metsä Group, is pleased to announce that the food safety procedures at its Kyro, Äänekoski and Husum mills have recently been certified according to the FSSC 22000 food safety standard. These certifications demonstrate that Metsä Board’s mill organisations comprehensively ensure the safety of their products for demanding end-uses, such as direct contact with food. The FSSC 22000 is a standard approved by the GFSI (Global Food Safety Initiative). It defines a

Swisscom selects Ericsson Security Manager

· Ericsson Security Manager solution to provide increased security automation, visibility and control for Swisscom Security Operation Center · Deal includes automation of security compliance management and basic security analytics · Partners are working together with progressive and agile collaboration to further develop Ericsson Security Manager solutionEricsson (NASDAQ: ERIC) has been selected by Swisscom, the leading telecommunications service provider in Switzerland, for its market-leading Ericsson Security Manager solution. Ericsson Security Manager will provide increased

NENT Group’s next original series is international drama ‘Commando’

· Series created and directed by Per-Olav Sørensen (‘Quicksand’; ‘Nobel’) · ‘Commando’ to premiere in the Nordic region exclusively on Viaplay · NENT Group set to premiere a minimum of 20 original productions every year Nordic Entertainment Group (NENT Group) is partnering with award-winning director Per-Olav Sørensen to create the international drama series ‘Commando’, based on actual events and set in Norway, Libya and the UK. The series will premiere across the Nordic region exclusively on NENT Group’s Viaplay streaming service. Between 15 February and 22 July 2011, Norwegian

Pharmacolog's Year-end Bulletin 2018

Press release: Uppsala, February 14, 2019. Pharmacolog i Uppsala AB’s (publ) Year-end Bulletin 2018 is now available on the company’s webbsite www.pharmacolog.com (Swedish only)Fjärde kvartalet 1 oktober 2018 – 31 december 2018 · Bolagets nettoomsättning för perioden uppgick till 771 (382)Tkr.  · Rörelseresultatet för perioden uppgick till -3 239 (-2 593) Tkr.  · Nettoresultat per aktie före och efter utspädning var för perioden -0,46 (-0,82) kr. Perioden 1 januari 2018 – 31 december 2018  · Bolagets nettoomsättning för perioden uppgick till 1 035 (798)Tkr.  ·

Change in Caverion’s management: Kari Sundbäck appointed to Group Management Board

Caverion Corporation Stock exchange release 14 February 2019 at 9.30 a.m. EETChange in Caverion’s management: Kari Sundbäck appointed to Group Management Board Kari Sundbäck, M.Sc. (Eng.), born 1971, will be appointed as Caverion’s Head of Transformation and Supply Operations and member of the Group Management Board at the latest as of 8 May 2019. He will report to Ari Lehtoranta, President and CEO of Caverion Group. Sundbäck’s responsibilities will include the supply operations, including procurement, the management of group-wide transformation initiatives and Communications.

MEDIVIR AB – YEAR END REPORT, JANUARY – DECEMBER 2018

Two new projects into clinicOctober – DecemberSignificant events during the quarter · The first patient was dosed in the phase II study with birinapant and Keytruda® as combination therapy in colorectal cancer. · The first patient with advanced cancer in the liver was dosed with the company's drug candidate MIV-818 in a phase Ia study. · MIV-828 was selected as a candidate drug for the treatment of acute myeloid leukemia (AML) and other forms of blood cancer. · Dr Uli Hacksell was appointed new CEO of Medivir. · A reorganization, with the aim of focusing the internal

Year-end report 2018

NET ASSET VALUE AND THE LATOUR SHARE ·The net asset value rose to SEK 100 per share, compared with SEK 95 per share at the start of the year. This is an increase of 8.3 per cent, adjusted for dividends. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) decreased by 4.4 per cent. The net asset value at year-end was negatively affected by the weak stock market in December. However, it has recovered after the end of the year and increased to SEK 109 per share on 13 February 2019. (1) ·The total return on the Latour share was 13.7 per cent during the year

YEAR-END REPORT 2018

FULL YEAR AND THE FOURTH QUARTER · Net sales amounted to MSEK 1,615.1 (657.6), of which the fourth quarter amounted to MSEK 463.3 (238.7). This corresponds to an increase of 146% for the full year, and 94% for the fourth quarter. A large part of the growth is attributable to products acquired during the period. · Organic growth was + 7.0% (proforma) for the period, and for the fourth quarter + 5.4%. Pharmaceutical drugs accounted for an organic growth of +3.2% for the period, and +5.8% for the fourth quarter. · EBITDA amounted to MSEK 632.2 (169.3), of which the fourth quarter

Year-End Report 2018:

“Best quarter ever in Mytaste Group’s history”myTaste AB (publ) Year-End Report for 2018 has now been made public and is available at https://mytastegroup.com/investors/financial-reports   CEO Andereas Friis comments: “With a record-breaking quarter behind us, we are one step closer of becoming the global market leader in performance-based marketing”I am pleased to announce that, the fourth quarter of 2018 for Mytaste Group was very strong, which is a confirmation that our strategy for becoming a leader in performance-based marketing works. We have both streamlined and developed

There are no items matching the current filter
There are no more items matching the current filter
Back to top